Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma. [electronic resource]
Producer: 20210910Description: 208-217 p. digitalISSN:- 2095-3941
- Biomarkers, Tumor -- analysis
- Cetuximab -- pharmacology
- Class I Phosphatidylinositol 3-Kinases -- genetics
- DNA Mutational Analysis
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Female
- Follow-Up Studies
- Gain of Function Mutation
- Head and Neck Neoplasms -- drug therapy
- Humans
- Immunohistochemistry
- Male
- Middle Aged
- Progression-Free Survival
- Proto-Oncogene Proteins p21(ras) -- genetics
- Squamous Cell Carcinoma of Head and Neck -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.